Lior sher, jd.
Lior Sher, JD, is the Founder and Executive Director of VCICI, the Vitamin C Institute for
Clinical Integration. A clinical strategist, medical researcher, author, educator, and attorney, she
works at the intersection of redox medicine, clinical implementation, law, and scientific
translation.
She is the author of The C Word, an unfiltered scientific exposé examining Vitamin C science,
clinical suppression, and therapeutic application.
Through VCICI, Lior advances clinician education in Vitamin C Therapy, terrain preparation and
optimization, protocol architecture, pharmacologic application, and biologic verification —
helping practitioners translate complex science into clinically actionable strategies designed to
improve patient experience, strengthen outcomes, differentiate their practices, and expand
clinical growth.
Presentation Title
Why Vitamin C Therapy Works in Some Patients — And Misses in Others
Terrain • Timing • Target
GOP ≠ BOT: Good On Paper ≠ Biologically On Target
Presentation Abstract
Vitamin C is one of the most studied — and most misunderstood — molecules in medicine. Yet
clinical outcomes remain highly variable because many protocols focus primarily on dose while
overlooking the biology receiving the intervention.
In this clinician-focused presentation, Lior Sher, JD, introduces a precision redox-medicine
framework for understanding why apparently similar Vitamin C protocols can produce markedly
different outcomes. The presentation moves beyond generic supplementation and routine IV
dosing to examine the variables that determine whether the intended biology is actually
reached: terrain preparation and optimization, baseline depletion and metabolic demand,
molecular form, route, timing, saturation, therapeutic target, and biologic verification.
Participants will distinguish physiologic Vitamin C support from pharmacologic Vitamin C
Therapy and examine how these principles apply across infectious disease, regenerative and
aesthetic medicine, oral-systemic and biological dentistry, integrative oncology, and other
complex chronic conditions.
Particular emphasis will be placed on terrain preparation as a critical determinant of
response across redox-modulating interventions, including antioxidant, oxidative, and
selectively pro-oxidant strategies such as high-dose IVC and ozone.
In infectious disease, inadequate response may reflect failure to meet increased ascorbate
demand or achieve sufficient repletion and saturation. In oncology, pharmacologic IV ascorbate
presents a different therapeutic objective requiring adequate exposure and biologic verification.
The central framework is simple:
Terrain • Timing • Target
GOP ≠ BOT: Good On Paper ≠ Biologically On Target.
Learning Objectives
By the conclusion of this presentation, participants will be able to:
1. Identify major biological and protocol-related factors responsible for variable responses
to Vitamin C Therapy, including terrain demand, baseline depletion, molecular form,
route, dosing rhythm, saturation, therapeutic target, and unverified exposure.
2. Differentiate physiologic Vitamin C support from pharmacologic Vitamin C Therapy and
explain how repletion, saturation, route, timing, therapeutic target, and verification
determine whether the intended biologic effect is reached.
3. Apply the Terrain • Timing • Target framework to clinical decision-making across
infectious disease, regenerative and aesthetic care, oral-systemic and biological
dentistry, integrative oncology, and other complex chronic conditions.
4. Recognize terrain preparation and optimization as a critical determinant of response
across redox-modulating therapies — including antioxidant, oxidative, and selectively
pro-oxidant interventions such as high-dose IVC and ozone — with infectious disease
and integrative oncology illustrating the importance of biologic demand, therapeutic
exposure, and verification.